Presentations (slides, Video) and Abstract are available to GBCC Sign-up members.
You can access after log-in.
Previous Meetings
GBCC 2019
Global Breast Cancer Conference 2019
10:00-11:15
Symposium 1
Tailoring Adjuvant Systemic Therapy
Venue: Premier Ballroom AB
-
Who Needs Systemic Chemotherapy?Yoon-Sim Yap (National Cancer Centre Singapore, Singapore)
-
Who Are Candidate for Ovarian Suppression & Extended Endocrine TherapyMasakazu Toi (Graduate School of Medicine, Kyoto Univ., Japan)
-
What's New for HER2 Positive Early Breast Cancer?Jee Hyun Kim (Seoul National Univ. Bundang Hospital, Korea)
Panel Discussion 1
What Can We Do for the Excellent Responders of Neoadjuvant Chemotherapy?
Venue: Premier Ballroom C
-
Good Responders: Who Are They?Yong Wha Moon (CHA Bundang Medical Center, CHA Univ., Korea)
-
Can We Eliminate Surgery in Exceptionally Excellent Responders?Mark Basik (Segal Cancer Center, Canada)
-
Radiation Oncologist's View for Escalation or De-escalationMi Young Kim (Kyungpook National Univ. Hospital, Korea)
Education Session 1
Recent Advance of Endocrine Treatment
Venue: 113-115
-
Optimal Sequence of Endocrine Treatment in Advanced Breast CancerSarat Chandarlapaty (Memorial Sloan Kettering Cancer Center, U.S.A.)
-
Overcome of Endocrine ResistanceHiroji Iwata (Aichi Cancer Center, Japan)
-
Late Recurrence in ER-positive Breast Cancer: Risk Prediction & TreatmentIan Smith (The Royal Marsden NHS Foundation Trust, United Kingdom)
Oral Presentation 1
Venue: 107-109
-
BREAST CANCER RATE AND MORTALITY IN FLIGHT ATTENDANTSMichael Co (The Univ. of Hong Kong, Hong Kong)
-
HORMONE REPLACEMENT THERAPY AND BREAST CANCER RISK IN A NATIONWIDE POPULATION-BASED COHORTTae-Kyung Yoo (The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)
-
ASSOCIATION BETWEEN OBESITY AND FIRMICUTES/BACTEROIDETES RATIO IN BREAST CANCER PATIENTSJeongshin An (Ewha Womans Univ. Mokdong Hospital, Korea)
-
NOVEL FUSION GENES IDENTIFIED FROM MATCHED PRIMARY AND RECURRED BREAST CANCERS BY RNA-SEQUENCINGSoojeong Choi (ASAN Medical Center, Korea)
-
BASAL AND IL-1β-INDUCED IL-8 IS SUPPRESSED BY CELASTROL IN TRIPLE NEGATIVE BREAST CANCERYisun Jeong (Sungkyunkwan Univ. School of Medicine, Korea)
-
APPLICATION OF 3D PRINTED BREAST SURGICAL GUIDE FOR BREAST CONSERVING SURGERY IN DCIS PATIENTSAisha Alzuhair (ASAN Medical Center, Saudi Arabia)
-
ROBOTIC VERSUS CONVENTIONAL NIPPLE SPARING MASTECTOMY AND IMMEDIATE PROSTHESIS BREAST RECONSTRUCTION IN THE MANAGEMENT OF BREAST CANCER- A CASE CONTROL COMPARISON STUDYHung-Wen Lai (Changhua Christian Hospital, Taiwan)
-
PHASE II RANDOMIZED STUDY OF NEOADJUVANT METFORMIN PLUS LETROZOLE VERSUS PLACEBO PLUS LETROZOLE FOR ER-POSITIVE POSTMENOPAUSAL BREAST CANCER [METEOR STUDY]Jisun Kim (ASAN Medical Center, Korea)
-
DEAD-BOX RNA HELICASE DP103 REGULATED SUMO/ACETYLATION SWITCH OF P53 DETERMINES RESPONSE TO DOCETAXEL IN ERα-POSITIVE BREAST CANCERAlan Prem Kumar (National Univ. of Singapore, Singapore)
Oral Presentation 2
Venue: 104-106
-
THE RISK OF CARDIAC DISEASE IN KOREAN BREAST CANCER PATIENTS: IMPACT OF PATIENT-SPECIFIC FACTORS AND HEART DOSE BASED ON INDIVIDUAL HEART DOSE CALCULATION FROM THREE-DIMENSIONAL RT PLANNINGSeung Yeun Chung (Yonsei Univ. College of Medicine, Korea)
-
INTERNAL MAMMARY LYMPH NODES INVOLVEMENT IN PATIENTS WITH BREAST CANCER: ANATOMICAL CHARACTERISTICS AND IMPLICATION FOR TARGET DELINEATIONYujie Wang (Shanghai Jiaotong Univ. Medical School Ruijin Hospital, China)
-
RISK OF LYMPHEDEMA FOLLOWING CONTEMPORARY TREATMENT FOR BREAST CANCER: AN ANALYSIS OF 7,426 CONSECUTIVE PATIENTS FROM A MULTIDISCIPLINARY PERSPECTIVEHwa Kyung Byun (Yonsei Univ. College of Medicine, Korea)
-
RADIATION PRACTICE PATTERNS AND IMPACT OF RADIOTHERAPY ON COMPLICATIONS AFTER BREAST RECONSTRUCTION: FINAL REPORT OF KROG 18-04Jee Suk Chang (Yonsei Univ. College of Medicine, Korea)
-
EFFECT OF POLOXAMER-BASED THERMO-SENSITIVE SOL-GEL ON SHOULDER MOTION AFTER AXILLARY LYMPH NODE DISSECTION IN PATIENTS WITH BREAST CANCER: A MULTI-CENTER DOUBLE-BLIND, RANDOMIZED CONTROLLED TRIALHee Jun Choi (Samsung Changwon Hospital, Korea)
-
GAS VERSUS GASLESS ROBOT-ASSISTED NIPPLE SPARING MASTECTOMYJeea Lee (Yonsei Univ. College of Medicine, Korea)
-
PRE-OPERATIVE TOMOSYNTHESIS-GUIDED HOOKWIRE NEEDLE LOCALISATION OF IMPALPABLE, MAMMOGRAPHICALLY AND SONOGRAPHICALLY OCCULT BREAST LESIONS: A PRELIMINARY EXPERIENCEVictor Chan (Queen Mary Hospital, Hong Kong)
-
OUTCOMES OF DUCTAL CARCINOMA IN SITU ACCORDING TO DETECTION MODALITY: A MULTICENTER STUDY COMPARING RECURRENCE BETWEEN MAMMOGRAPHY AND BREAST USJung Hyun Yoon (Yonsei Univ. College of Medicine, Korea)
11:30-12:15
Plenary Lecture 1
Venue: Premier Ballroom AB
-
Evolution of Therapeutic Strategies for Hormone Receptor-positive, HER2-negative Breast CancerNadia Harbeck (Univ. of Munich (LMU), Germany)
12:30-13:15
Satellite Symposium 1
Venue: Premier Ballroom AB
-
Leading the Way in the Treatment of HR+ HER2-mBC: Palbociclib & CDK4/6 Inhibitors in Clinical PracticeHope S. Rugo (Univ. of California San Francisco Medical Center, U.S.A.)
13:45-14:30
Plenary Lecture 2
Venue: Premier Ballroom AB
-
Current Trends and Future Directions in Bench to Bedside Translational Research in ER-positive Breast CancerCarlos Arteaga (UT Southwestern Harold C. Simmons Cancer Center, U.S.A.)
14:45-16:00
Symposium 2
TNBC: Where Are We and What’s Next Destination?
Venue: Premier Ballroom AB
-
Potential Therapeutic Targets: Androgen Receptor, PI3KCA, MEK, etc.Sung-Bae Kim (ASAN Medical Center, Korea)
-
BRCA and DNA Repair ImpairmentSeock-Ah Im (Seoul National Univ. Hospital, Korea)
-
Optimal Treatment of TNBC with Cytotoxic ChemotherapyRebecca Alexandra Dent (National Cancer Centre Singapore, Canada)
Panel Discussion 2
Up-to-date Management of Premalignant Lesion
Venue: Premier Ballroom C
-
Risk Stratification of Premalignant Breast LesionsAeree Kim (Korea Univ. Guro Hospital, Korea)
-
Surgery for Lobular Carcinoma in Situ: To Do or Not to Do?Masahiro Takada (Kyoto Univ. Hospital, Japan)
-
How to Manage Suspicious Microcalcifications?Jonghan Yu (Samsung Medical Center, Sungkyunkwan Univ. School of Medicine, Korea)
Education Session 2
Prediction and Risk Assessment of Breast Imaging
Venue: 113-115
-
Quantitative Imaging for Breast Cancer Risk AssessmentEmily Conant (Univ. of Pennsylvania, U.S.A.)
-
Early Prediction of Response from Neoadjuvant TherapyBong Joo Kang (The Catholic Univ. of Korea, Seoul St. Mary's Hospital, Korea)
-
Application of AI in Diagnosis of Breast Cancer with Digital MammographyEun-Kyung Kim (Yonsei Univ. Severance Hospital, Korea)
Survivorship Session 1
Healthy Living after Breast Cancer Treatment from Psycho-oncologists’ Perspectives
Venue: 107-109
-
Complex Relationship among Depression, Self-efficacy, Illness Perception, and Fear of Progression in Breast Cancer SurvivorsEun-Jung Shim (Pusan National Univ., Korea)
-
Understanding the Causes of Distress in Breast Cancer Patients and SurvivorsRichard Fielding (Univ. of Hong Kong, Hong Kong)
-
Sleep & Depression: Two Important Psychiatric Symptoms in Psycho-oncologySeockhoon Chung (ASAN Medical Center, Korea)
Junior Doctors Forum 1
Venue: 104-106
-
My Journey with Endocrine Therapy and Future Perspectives on Young Asian DoctorsIan Smith (The Royal Marsden NHS Foundation Trust, United Kingdom)
16:15-17:30
Symposium 3
Immunity, Immunotherapy, and Breast Cancer
Venue: Premier Ballroom AB
-
Current Trends in Immuno-oncologyEui-Cheol Shin (Korea Advanced Institute of Science and Technology (KAIST), Korea)
-
Immunotherapy in Breast Cancer: Biomarkers and Correlative StudiesPrudence Francis (Peter MacCallum Cancer Centre, Australia)
-
Breast Cancer Subtypes & ImmunotherapyGiuseppe Curigliano (Istituto Europeo di Oncologia, Italy)
Panel Discussion 3
Breast Cancer and Bone Metastasis: from Microenvironment to Macroenvironment
Venue: Premier Ballroom C
-
Bone Physiology and Pathogenesis of Bone MetastasisSun Wook Cho (Seoul National Univ. Hospital, Korea)
-
Surgical Consideration for Bone Metastasis from Breast CancerWanlim Kim (ASAN Medical Center, Korea)
-
Optimization of Radiation Therapy for Bone MetastasisHaeyoung Kim (Samsung Medical Center, Korea)
Education Session 3
Recent Advance of MRI and Its Application
Venue: 113-115
-
Abbreviated Breast MRI for High Risk PatientsChristiane Katharina Kuhl (RWTH Aachen, Germany)
-
Non-contrast MRI for Screening and Surveillance of Breast CancerHee Jung Shin (ASAN Medical Center, Korea)
-
Application of Ultrafast MRI to Real PracticeNariya Cho (Seoul National Univ. Hospital, Korea)
Survivorship Session 2
Cancer Chronotherapy: A Right Time in the Day to Treat
Venue: 107-109
-
Association between Circadian Disruption and Breast CancerTae Kim (GIST (Gwangju Institute of Science and Technology), Korea)
-
Mutations in Circadian Genes and Their Mechanistic Connection to Cancer DevelopmentCarla Finkielstein (Virginia Tech, U.S.A.)
-
Circadian Rhythm of p53 toward the Chronotherapy of CancerJae Kyoung Kim (Korea Advanced Institute of Science and Technology (KAIST), Korea)
Junior Doctors Forum 2
How to Globalize the Society You Are Involved in
Venue: 104-106
-
How to Globalize the Society You Are Involved inSeigo Nakamura (Showa Univ. School of Medicine, Japan)
-
How to Globalize Your Career: 30 Years Experience from the Mind to the Global Stent MarketHo-Young Song (ASAN Medical Center, Korea)
-
Introduction to Journal of Breast CancerYongsik Jung (Ajou Univ. Hospital, Korea)